Ping An Biomedical Co., Ltd. cash flow statement PASW

Annual Quarterly

In fiscal 2025, which ended Sep 30, 2025, Ping An Biomedical Co., Ltd. used $902,902 of cash from operations.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line
FY 2025
Sep 30, 2025
Operating
Depreciation and amortization
0
Operating cash flow
-1
Financing
Short-term debt issued
1
Short-term debt repaid
1
Financing cash flow
6
Change in cash
Effect of exchange rate
-0
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Apparel & Other Finishd Prods of Fabrics & Similar Matl (SIC 2300)
Listed as
PASW (Nasdaq)
Incorporated in
Cayman Islands
Headquarters
Cheung Sha Wan, Kowloon
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1897532
Former names
Majestic Ideal Holdings Ltd (until Sep 29, 2025)

Other Apparel & Other Finishd Prods of Fabrics & Similar Matl companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.